This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK, Jan. 27, 2014 /PRNewswire/
-- Harwood Feffer LLP (
www.hfesq.com) is investigating potential claims against the board of directors of SciClone Pharmaceuticals, Inc. ("SciClone" or the "Company") (NASDAQ: SCLN), concerning whether the board has breached its fiduciary duties to shareholders.